Ranibizumab monoclonal antibody fragment (Fab) drug. Targets VEGFA and is indicated for the treatment of age-related macular degeneration (AMD). Generic name and stylized antibody representation.
Choose your region
Selecting a region may change the language and promotional content you see on the Adobe Stock web site.